Jiřı́ Vrba
Impact in
- Biochemistry top 2%
- Phytochemicals and Antioxidant Activities
- Pharmacology top 2%
- Berberine and alkaloids research
- Pharmacogenetics and Drug Metabolism
Papers in
- Pharmacology 19
- Berberine and alkaloids research 14
- Pharmacogenetics and Drug Metabolism 8
- Drug-Induced Hepatotoxicity and Protection 3
-
- Phytochemicals and Antioxidant Activities 5
- Co-authors
- Jitka Ulrichová (33 shared papers)Vladimı́r Křen (18 shared papers)Kateřina Valentová (7 shared papers)Martina Bancı́řová (1 shared paper)Martin Modrianský (10 shared papers)Jan Vacek (20 shared papers)Barbora Papoušková (16 shared papers)Petr Doležel (3 shared papers)
In The Last Decade
Jiřı́ Vrba
52 papers receiving 1.5k citations
Peers
Comparison fields: 5 of 110
- Biochemistry 228
- Pharmacology 248
- Pharmacology 354
- Complementary and alternative medicine 88
- Molecular Biology 627
Countries citing papers authored by Jiřı́ Vrba
This map shows the geographic impact of Jiřı́ Vrba's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jiřı́ Vrba with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jiřı́ Vrba more than expected).
Fields of papers citing papers by Jiřı́ Vrba
This network shows the impact of papers produced by Jiřı́ Vrba. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jiřı́ Vrba. The network helps show where Jiřı́ Vrba may publish in the future.
Co-authors
The 25 scholars most cited alongside Jiřı́ Vrba, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 52 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2014 | 410 | |
| 2 | 2015 | 77 | |
| 3 | 2009 | 64 | |
| 4 | 2008 | 61 | |
| 5 | 2012 | 60 | |
| 6 | 2002 | 57 | |
| 7 | 2011 | 47 | |
| 8 | 2013 | 47 | |
| 9 | 2015 | 42 | |
| 10 | 2017 | 37 | |
| 11 | 2011 | 37 | |
| 12 | 2004 | 36 | |
| 13 | 2020 | 32 | |
| 14 | 2007 | 30 | |
| 15 | 2018 | 29 | |
| 16 | 2012 | 29 | |
| 17 | 2013 | 28 | |
| 18 | 2014 | 26 | |
| 19 | 2003 | 25 | |
| 20 | 2018 | 24 |
About Jiřı́ Vrba
Jiřı́ Vrba is a scholar working on Pharmacology, Pharmacology, Biochemistry, Molecular Biology and Pulmonary and Respiratory Medicine, having authored 52 papers that have together received 1.5k indexed citations. Recurring topics across this work include Berberine and alkaloids research (14 papers), Silymarin and Mushroom Poisoning (10 papers), Pharmacogenetics and Drug Metabolism (8 papers), Genomics, phytochemicals, and oxidative stress (8 papers), Synthesis and bioactivity of alkaloids (6 papers), Phytochemicals and Antioxidant Activities (5 papers), Free Radicals and Antioxidants (4 papers) and Drug-Induced Hepatotoxicity and Protection (3 papers). The work is most often cited by research in Biochemistry (228 citations), Pharmacology (248 citations), Pharmacology (354 citations), Complementary and alternative medicine (88 citations) and Molecular Biology (627 citations). Jiřı́ Vrba has collaborated with scholars based in Czechia, Poland and France. Frequent co-authors include Jitka Ulrichová, Vladimı́r Křen, Kateřina Valentová, Martina Bancı́řová, Martin Modrianský, Jan Vacek, Barbora Papoušková, Petr Doležel, Jaroslav Vičar and Martina Zatloukalová. Their work appears in journals such as Journal of Pharmaceutical and Biomedical Analysis, Toxicology in Vitro, Toxicology Letters, Free Radical Biology and Medicine and International Journal of Molecular Sciences.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.